“DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUSType 2 Diabetes Mellitus Is a Common Chronic Disease That Causes Significant Morbidity and Mortality Worldwide. Diabetes Results from a Combination of Increased Hepatic Glucose Product”. International Research Journal of Pharmacy, vol. 2, no. 1, Nov. 2024, pp. 32-40, https://irjponline.org/index.php/irjp/article/view/1741.